Evidence map›Paper›PMID 25952756›Full record

ArticleFamilial cancer2015

Genotype-phenotype analysis of von Hippel-Lindau syndrome in fifteen Indian families.

Narendranath Vikkath, Sindhu Valiyaveedan, Sheela Nampoothiri, Natasha Radhakrishnan, Gopal S Pillai, Vasantha Nair, Ginil Kumar Pooleri, Georgie Mathew, Krishnakumar N Menon, Prasanth S Ariyannur and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Familial cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Narendranath VikkathDepartment of Neurosurgery, Amrita Institute of Medical Sciences and Research Center, AIMS Ponekkara P.O., Kochi, 682041, India.
Sindhu ValiyaveedanMazumdar-Shaw Centre for Translational Research, Mazumdar-Shaw Cancer Centre, Bangalore, India.
Sheela NampoothiriDepartment of Pediatric Genetics, Amrita Institute of Medical Sciences and Research Center, AIMS Ponekkara P.O., Kochi, 682041, India.
Natasha RadhakrishnanDepartment of Ophthalmology, Amrita Institute of Medical Sciences and Research Center, AIMS Ponekkara P.O., Kochi, 682041, India.
Gopal S PillaiDepartment of Ophthalmology, Amrita Institute of Medical Sciences and Research Center, AIMS Ponekkara P.O., Kochi, 682041, India.
Vasantha NairDepartment of Endocrinology, Amrita Institute of Medical Sciences and Research Center, AIMS Ponekkara P.O., Kochi, 682041, India.
Ginil Kumar PooleriDepartment of Urology, Amrita Institute of Medical Sciences and Research Center, AIMS Ponekkara P.O., Kochi, 682041, India.
Georgie MathewDepartment of Urology, Amrita Institute of Medical Sciences and Research Center, AIMS Ponekkara P.O., Kochi, 682041, India.
Krishnakumar N MenonCenter for Nanosciences and Molecular Medicine, Amrita Institute of Medical Sciences and Research Center, AIMS Ponekkara P.O., Kochi, 682041, India.
Prasanth S AriyannurDepartment of Neurosurgery, Amrita Institute of Medical Sciences and Research Center, AIMS Ponekkara P.O., Kochi, 682041, India. prasanthas@aims.amrita.edu.ORCID http://orcid.org/0000-0003-0888-8094
Ashok B PillaiDepartment of Neurosurgery, Amrita Institute of Medical Sciences and Research Center, AIMS Ponekkara P.O., Kochi, 682041, India. brashok@aims.amrita.edu.
Amrita Institute of Medical Sciences and Research Centre · INMazumdar Shaw Medical Foundation · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The general prevalence of the familial multi-organ tumor disorder, von Hippel-Lindau syndrome (VHL), was estimated to be 1 in 25-40,000 in western studies two decades back. Few studies were done in Indian sub-continent, amidst a surge in clinical reports on VHL specific manifestations. The syndrome is correlated with mutations of the gene VHL (located in Chr 3p25.3). We aimed to conduct a prospective case series describing phenotypic and genotypic characteristics in Indian population. The VHL-specific clinical and radiological features were collected from patients and family members. Genotypic changes such as deletion/duplication or point mutation in the VHL locus were identified using sequencing and MLPA. Thirty-one subjects, from fifteen families with diagnosed VHL, were included in the study. Multicystic pancreas was found in 71% (22/31), CNS hemangioblastoma in 68% (21/31), renal cell carcinoma and retinal angiomas in 23% (7/31) each, pheochromocytoma in 9.7% (3/31) of the population and endolymphatic sac tumor in one subject. Four families (9 subjects) had full length deletion of VHL, three families (4 subjects) had a deletion of exon 3, eight families (18 subjects) had different exonic, splice-site and intronic point mutations and one subject had a de novo in-frame indel in exon 1. Multicystic pancreas and CNS hemangioblastomas were the most common manifestations in our population. The phenotypic expression patterns in terms of tumorigenesis, tissue tropism and penetrance in comparison to the genotypic features were found to be different from previous correlative studies.

Indexed as

AdolescentAdultAgedBiomarkers, TumorChildChild, PreschoolFemaleFollow-Up StudiesGenotypeHumansIndiaMaleMiddle AgedMutationNeoplasm StagingPhenotypeBiomarkers, TumorVHL protein, humanVon Hippel-Lindau Tumor Suppressor ProteinGenotype–Phenotype correlationIndiaMutationVHLvon Hippel–Lindau syndrome

Identifiers

PMID25952756
OpenAlexW747101786

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.